Skip to main content

Fusarium

NDC 49643-111 · Allermed Laboratories, Inc.

Generic nameFusarium solani
Dosage formINJECTION
RouteCUTANEOUS, INTRADERMAL, SUBCUTANEOUS
Active ingredient(s)HAEMATONECTRIA HAEMATOCOCCA
Strength.1 g/mL
Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]
Marketing categoryBLA

Packages

49643-111-05 — 5 mL in 1 VIAL, MULTI-DOSE (49643-111-05)

49643-111-10 — 10 mL in 1 VIAL, MULTI-DOSE (49643-111-10)

49643-111-30 — 30 mL in 1 VIAL, MULTI-DOSE (49643-111-30)

49643-111-50 — 50 mL in 1 VIAL, MULTI-DOSE (49643-111-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

22840-1676 — Fusarium solani, 22840-1677 — Fusarium solani, 22840-1678 — Fusarium solani, 22840-5619 — Fusarium solani, 22840-9636 — Gibberella fujikuroi and Fusarium solani, 22840-9637 — Gibberella fujikuroi and Fusarium solani, 22840-9638 — Gibberella fujikuroi and Fusarium solani, 22840-9639 — Gibberella fujikuroi and Fusarium solani, 22840-9641 — Gibberella fujikuroi and Fusarium solani

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels